Summary: Researchers know that changes in gut microbiota have an adverse impact on mental health management. These changes are among the significant reasons for the rise of common mental health problems. Using germ-free mice, researchers can now understand the role of different types of gut microbiota in mental health. Additionally, they can also start using gut microbiota to manage mental health issues. It means that science can now progress from developing the understanding to practical application.

Different types of mental illnesses like anxiety, depression, amyotrophic lateral sclerosis (ALS), and various neurodegenerative diseases are rising. However, science has been struggling to explain why these mental health disorders have been rising so briskly in the last few decades. It now appears that most adults are living with one or another common mental health problems.

It is pretty easy to guess that it has much to do with a fast-changing environment. These diseases used to be rare just a century back. So, it means that fast-changing environmental factors and lifestyles predispose humans to mental health issues.

However, perhaps the bigger question remains: What kind of environmental and lifestyle changes are causing a rise in mental health issues, what is the role of various such changes, and what is the underlying mechanism? 

It is not easy to understand, as tens of factors are implicated in the rise of mental health issues. One such factor contributing to the increase in mental health issues is dysbiosis or severe changes in the gut microbiota. It has been seen that painkiller addiction helps in the rise of such cases as well. 

Studies show that changes in gut microbiota may affect physical and mental health. But, understanding what changes cause these health disorders is challenging. There are trillions of microorganisms living in the gut, and health disorders occur due to minor changes in their population. Therefore, understanding these small changes in the population of gut microbiota is very challenging. Nonetheless, researchers have been making some progress.

To understand how gut microbiota influences mental and physical health, researchers use so-called germ-free mice. These are mice that lack any kind of gut microflora. Then by introducing gut microflora in these mice, researchers can see the impact of different types of microbiota on mental and physical health. This helps us understand how and what changes in the gut microbiota are harmful and suggests ways of normalizing gut microbiota.

Researchers now know that gut microbiota produces neurotransmitters, short-chain fatty acids, bile acids, vitamins, lactate, and many other bioactive compounds, thus impacting health. They are now also learning to appreciate the importance of various bioactive compounds produced by gut microbiota, modulating their levels by tweaking the gut microbiota.

In the future, researchers think that understanding how to use microbiota to alter the production of various bioactive compounds may help manage most mental health disorders, from depression, and amyotrophic lateral sclerosis (ALS), to autism spectrum disorder (ASD).

There are many good things about such a therapy. First, it is a more natural way to treat mental health disorders. Such methods may work slowly, but they can provide prolonged relief without causing any significant side effects.

Moreover, it is vital to understand that though there are hundreds of medications to treat mental health disorders, they work only in a small number of cases. Additionally, these drugs cause severe side effects.

Just take the example of depression. There are tens of drugs to treat the condition. Yet, these drugs barely work in less than half of all cases. It means that medications almost completely fail to help in more than 50% of the cases. Even worse, they have many side effects, they help slowly, and people must take these medications for long, sometimes even lifelong.

Unlike medical drugs, novel therapies like using gut microbes may provide prolonged relief. Moreover, once the healthy gut population has been reinstated, one can start living without the need to take any medications. Thus, such an approach is not only safe, but it also helps mental health management. 

It is therefore suggested to take expert help in case of common mental health problems. Telehealth addiction treatment offered by Addictionology Center helps you in mental health management right in the comfort of your home. 

Summary: Alcohol use disorder is a significant problem in the US and is associated with significant mortality. However, there are very few medications to treat alcohol use disorder. Now a new study suggests that one of the commonly available medications used to treat hypertension may help reduce alcohol cravings. A recent study found that those who used this medication to manage heart issues or hypertension reported significantly reduced alcohol intake. The drug was especially good for reducing alcohol intake in those with the highest alcohol intake.

Excessive alcohol consumption is a significant problem in the US. It causes 380 deaths a day or 140,000 deaths each year. Yes, these numbers are massive. Moreover, many of those who die due to excessive alcohol use are relatively young adults. Additionally, millions of lives are affected by excessive alcohol consumption. 

Though most are able to drink alcohol responsibly, nonetheless, alcohol use disorder is a significant issue in the US and globally. Alcohol is readily and legally available, and more than 80% of adults use alcohol now and then. Thus, no surprise that many use alcohol excessively.

Despite alcohol use disorder being an age-old problem, it has received relatively little attention. However, many people living with the condition require medical treatment for painkiller addiction help. Regretfully, very few drugs are moderately effective in the condition. Thus, doctors may use medications affecting alcohol metabolism, making alcohol consumption unpleasant. Or they might use drugs that reduce alcohol cravings. However, most medicines used to treat alcohol use disorders are moderately effective. Unfortunately, some of them have unpleasant side effects. Thus, researchers are looking for safer and more effective remedies, and it appears that one such remedy may be one of the popular heart medicine.

This popular heart medicine is called spironolactone. It is a diuretic used to manage hypertension. It has been in clinical use for a long, and thus it has a proven safety track record. However, now animal studies and clinical trials suggest that it may be quite good for treating alcohol use disorder, as it reduces alcohol cravings. The findings of the latest study were published in Molecular psychiatry2.

Spironolactone is an exciting drug in many ways, and studies have shown that it has many other health effects. That is why doctors are also exploring it for other brain disorders. It is even used to manage hair loss and many other health issues.

Researchers found that when mice were given spironolactone, they had a reduced urge to drink alcohol. Similarly, studies show that when spironolactone is prescribed for treating high blood pressure, people also report reduced alcohol intake due to a reduced urge to use alcohol.

Studies suggest that this may have something to do with its influence on mineralocorticoid receptors. These receptors are located throughout the brain and other organs that play an important role in fluid and electrolyte balance. It appears that expression or, rather, overexpression of these receptors in the brain has something to do with alcohol use disorder. Consequently, blocking these receptors appears to reduce alcohol urges or cravings in those living with alcohol use disorder.

In the study, researchers analyzed US Veterans Affairs healthcare system data and found that those taking spironolactone reported reduced alcohol intake. Interestingly, researchers found that those with the highest alcohol intake were more likely to reduce their intake after treatment with spironolactone.

Researchers say that these findings are highly encouraging. It is well-known that spironolactone is a nonselective mineralocorticoid receptor (MR) antagonist. Furthermore, it appears to modulate alcohol-seeking behavior by acting on these receptors in the brain.

Investigators also found that spironolactone independently reduced alcohol intake. In addition, its dose-dependently reduced alcohol self-administration. 

Researchers say that there is strong evidence from studies in rodents and clinical trials that it works. Thus, there is an urgent need to further test this drug for treating alcohol use disorder. Since the drug is already approved for treating other health conditions, it can be readily introduced for alcohol use disorder management. Repurposing a drug already in clinical use is much easier than developing some new treatment.

Summary: Cases of PTSD are on the rise globally, yet there are very few effective treatments for the condition. To date, psychotherapy is the most effective way of managing the condition. New studies show that MDMA or psilocybin may significantly increase the effectiveness of psychotherapy. It appears that these substances, when used as medications or part of PTSD treatment, make individuals more receptive to psychotherapy, thus helping rewire the brain faster.

Due to covid and various international conflicts like the Ukraine war, PTSD is on the rise in the US and globally. However, it is among the conditions that are still not treated effectively with existing drug therapy. Moreover, even if medications help, they take a long time to show results. Thus, there is a need to find medications that act fast, are effective, and are safe for managing the condition.

Researchers are testing many treatments. However, it appears that MDMA (“ecstasy”) and psilocybin (“magic mushroom”) are now among the most promising remedies. These remedies appear to act fast and are especially good for managing PTSD when combined with psychotherapy. A recent study regarding their promising role in PTSD management has been published in the journal European Neuropsychopharmacology. 

These therapies are not to replace psychotherapy. Instead, they work better when combined with them. Psychological counseling remains the most effective and safe way to manage PTSD. However, combining it with MDMA or psilocybin may result in significantly better results.

It appears that due to some inherent qualities, some people are prone to PTSD. Those affected by the condition develop severe issues like nightmares, intrusive thoughts, mood swings, avoidance, and various other physical and emotional reactions. In addition, they sometimes find it difficult to control these physical and emotional responses, causing significant disability. 

Researchers say psychotherapy remains the treatment of choice, as it is the only way to rewire their brains. However, psychotherapy is a prolonged and often quite expensive process. In addition, it means that using it on a massive scale is quite challenging. 

Of course, there are many other drugs in development. However, researchers say that MDMA and psilocybin are among the most promising agents. Here it is vital to understand that these drugs mainly work by increasing the action of psychotherapy and not due to their hallucinogenic properties. They may help individuals become more receptive to psychological instructions. In addition, they ensure better and faster brain rewiring. 

Researchers have already done 4 larger clinical studies. In all the studies, they found that combining psychotherapy with psychedelics was better than psychotherapy alone1.

Of course, “ecstasy” and “magic mushroom” are still the substance of abuse. Thus, their use in medicine is not legal. However, now things are changing fast, as regulatory agencies realize their benefits in PTSD. Hence, it is expected that MDMA may get approval for managing PTSD in a couple of years.

Clinicians are very excited about the perspectives of MDMA approval for clinical use, as they think that it will revolutionize PTSD treatment. Not only that, but it will also open doors for testing these therapeutic approaches in other mental health conditions. For example, there is already sound evidence that psychedelics are quite good for managing depression when used along with psychotherapy.

If approved, doctors will have a potent tool in their hands to rewire patients’ brains. 

Moreover, it is worth understanding that MDMA was created by a pharmaceutical company a long time ago. However, when it was created, doctors tested it for other health conditions, in which MDMA did not work well. 

Additionally, it appears that doctors and regulatory agencies are now changing their attitudes toward MDMA. Though its uncontrolled use may pose a health risk, when used under medical supervision or in the clinics, it is a highly safe way to manage various mental health issues.

Summary: In the US, more than a million suicides are attempted each year, causing more than 45000 deaths, most of which are young adults. Yet, there is no known effective treatment to reduce suicides significantly. Now a new study shows that a simple measure of using a folic acid supplement may reduce suicide risk by as much as 44%.

This is a very unusual and accidental finding of one of the new studies showing that folic acid may considerably reduce suicide risk.

it has long been known that vitamins are associated with better mental health, brain health, and energy levels, especially vitamin Bs. However, no one thought that it could reduce the suicide rate in such a significant manner, particularly in the case of opioid addiction treatment. Suicides or attempted suicides are generally associated with depression, and almost close to 5% of US adults are living with the condition. Each year about 12 million think of suicide and 10% of them attempt it, and it results in more than 45,000 deaths every year.

Despite so much progress in science, mental health disorders are increasing. There are tens of drugs to treat depression, yet none seems to work in all cases. Anti-depressants are moderately effective in treating depression. But, even worse, they fail to help in many instances.

In the new study published in the journal JAMA Psychiatry, researchers were looking for a possible association between depression risk and the use of various medications, a subject that is poorly explored yet.

For the purpose of the study, researchers analyzed the data of close to a million patients. They used the drug refill data to see if there is any association between the intake of various drugs and suicide risk. To understand this, they almost analyzed the patients’ use of close to 1000 drugs. To their surprise, their analysis showed that folic acid appears to be associated with significantly lower suicide risk.

Therefore, they decided to focus particularly on folic acid, also known as vitamin B9. The role of vitamin B-complex in brain health is known. Therefore, folic acid is often prescribed during prenatal care as it is essential for fetal brain development and reduces the risk of certain congenital disabilities.

For this purpose, they collected data from 866,586 patients who were given folic acid between 2012 to 2017. Since folic acid is more commonly prescribed to women, overwhelming numbers of those who took folic acid were women (80%).

When they analyzed the data, they found that people who took folic acid had a significantly lower suicide risk. However, since most patients who used folic acid were pregnant women, it is easy to understand such findings. Pregnant women are the least likely to commit suicide.

Nonetheless, researchers decided to move forward with their study and analyze the data of males. They were amazed to see that in men, folic acid intake reduced suicide risk by almost 44%, even after adjusting for various other confounding factors. These are incredible findings, as folic acid is readily available and is quite safe for prolonged use2.

There were some other interesting findings in the study, like a linear relationship between folic acid intake and reduced risk of suicides. The study found that folic supplementation for each month reduced suicide risk by about 5% and maxed out at about 44%. That is a massive benefit.

Since folic acid has many health effects similar to cyanocobalamin or vitamin B12, the researchers also decided to see if vitamin B12 could also help reduce suicide risk. However, they did not find any correlation between vitamin B12 intake and suicides. Hence, it appears that this benefit is unique to folic acid.

These findings have huge clinical relevance and must be tested in further well-designed clinical trials. It is vital to understand why folic acid is so helpful in preventing suicides. It is also essential to explore its role in treating depression.

If these findings are confirmed in clinical trials, then folic acid may emerge as a cheap and safe treatment for depression and preventing suicides, and it may help save thousands of lives.

Summary: Corticosteroids are among the most commonly used drugs. They are used to manage various health conditions, from pain, inflammation, allergies, and autoimmune disorders. However, their prolonged use is also associated with many side effects, including a higher risk of mood swings, depression, reduced cognition, and more. A new study comparing MRI brain scans of steroid users with non-users found that these effects on mental health are due to structural changes in the brain that occur due to prolonged use of steroids.

Steroids are among the most commonly used drugs to manage pain and inflammation. They are among the most common medications for allergies and autoimmune diseases. Quite often, people have to use steroids continually for years to keep their disease condition in control. Here, of course, we are talking about corticosteroids, not androgens, which are performance-enhancing drugs. The human body has many different steroidal hormones with various functions. Sex hormones are not the only steroids. Corticosteroids are very close to the hormones secreted by the adrenal gland in their structures.

Corticosteroids are the drugs of choice for managing severe asthma, autoimmune disorders, and even chronic pain. Doctors may prescribe these drugs for either inhalation or oral intake. Though these drugs are relatively safe when inhaled, on prolonged use, inhaled and oral drugs have similar side effects. Some of the common side effects of corticosteroids are increased infection risk, water retention, high blood pressure, mood swings, behavioral changes, stomach upset, weight gain, and more. Doctors have long known these side effects. Nonetheless, they have to prescribe these medications for many disease conditions, as there are no other options. Online addiction counseling is also a helpful treatment option for those who suffer from addiction, including opioid dependence. Combining corticosteroids with online addiction counseling may help to manage chronic pain and opioid dependence more effectively.

For example, inhaled corticosteroids are the most effective treatment for many asthma patients. Similarly, doctors may require using corticosteroids to manage chronic inflammatory conditions. Though doctors have long known that corticosteroids cause mood swings and symptoms like anxiety, depression, mania, and other mental health issues, but they do not know the cause of these side effects. They are unsure if these side effects are due to some metabolic changes, hormonal changes, altered levels of neurotransmitters, or something else. Now, study shows that these mental health issues probably arise due to structural brain changes caused by prolonged corticosteroid use.

In the new study, researchers used a UK biobank that contains data from more than half a million adults aged 40 to 69 years. For their study, researchers analyzed the MRI brain scans of 222 people using systemic steroids and another 557 using inhaled steroids. In addition, they compared their brain scans with 24,106 non-steroid users.

The study found that both inhaled and systemic steroid use was associated with structural brain changes like reduced white and gray matter in the brain. It means that neuronal connectivity is compromised by prolonged steroid use. The study found that white matter structures were especially less intact in long-term steroid users. Needless to say, researchers also found that such brain damage was more prominent in oral steroids users compared to inhaled steroids users. 

Additionally, the study found systemic steroid use resulted in larger caudate, whereas inhaled steroids caused a smaller amygdala. Both these structures play important roles in cognition and emotional processing. These structural changes in the brain of systemic steroid users were also associated with more severe signs of depression, fatigue, restlessness, and apathy. 

It is among the first studies to show that prolonged corticosteroids cause structural changes in the brain, which results in neuropsychiatric side effects. Moreover, the study found that such side effects are common with oral and inhaled corticosteroids. Corticosteroids are widely used drugs and are regarded as irreplaceable in many disease conditions. Thus, researchers say that this study shows an urgent need to find safer alternatives to synthetic corticosteroids.

Summary: Alzheimer’s is among the most common neurodegenerative disorders. There are no medical drugs that can cure it. A new study shows that high omega-3 intake at a young age is a way to improve brain function and have higher hippocampal volume. Thus, higher omega-3 intake at a young age may help reduce the risk of developing Alzheimer’s later in life and promote mental health improvement.

As people live longer, brain disorders continue to increase. Though there are many neurodegenerative disorders, Alzheimer’s is particularly a cause of concern. There are already 6.5 million Americans living with the condition, and these numbers are expected to keep rising.

Currently, no drug can help prevent Alzheimer’s or reverse it. Medications used to treat Alzheimer’s can only slow down its progress. 

More than a century of research into the subject has failed to provide sufficient information about the condition. Studies show that people are more likely to be diagnosed with the condition after the age of 65, though some might be diagnosed earlier. 

Nonetheless, studies do provide some valuable information. It appears that Alzheimer’s starts much earlier than its diagnosis. One develops its symptoms only when considerable damage has been done. Therefore, any measure to reduce Alzheimer’s risk must be initiated early.

Though doctors cannot reliably assess the risk of Alzheimer’s in all patients, studies show a high association of the condition with genetics. For example, those who carry the APOE4 gene are at considerable risk of developing Alzheimer’s later in life. Thus, these individuals can start their efforts to prevent disease early, even if they do not have any symptoms of the condition.

Many nootropics can boost various brain functions. However, it is unclear what health supplements may really help reduce the risk of Alzheimer’s. Now a new study provides sound evidence that high omega-3 intake may be associated with better brain health and may help reduce Alzheimer’s risk.

It is no secret that omega-3 fatty acids are good for brain health. Among three omega fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are especially good for brain health. Many clinical studies have shown that they are suitable for brain development, help considerably improve metabolic health, and boost various brain functions.

Now a new study shows that the benefits of omega-3 intake can even be visualized using brain scans. Those with high omega-3 intake have visibly higher hippocampal volume, a brain area associated with memory and learning. 

A study in 2,183 healthy individuals who were dementia and stroke-free found that if one starts taking omega-3 fatty acids in middle age, it may significantly reduce the risk of neurodegenerative disorders. In addition, omega-3 may help high-risk individuals like those with the APOE4 gene variant.

In the study, researchers noted higher hippocampal volume associated with higher omega-3 intake and found that omega-3 fatty acids helped improve reasoning and other brain functions. Not only that but omega-3 also helped by improving the functioning of small blood vessels in the brain. 

In their study, researchers divided participants into two groups, one with a very low omega-3 concentration in their blood cells and another group with a relatively high omega-3 concentration in their blood.

Most of the benefits mentioned above were only seen in those with high omega-3 fatty acids in blood cells. This is the first study to show such a relation between high omega-3 fatty acids intake and brain health in young adults.

Needless to say, those with healthier brains in middle life are also less likely to develop Alzheimer’s. It means that higher omega-3 intake is especially vital for high-risk individuals.

Omega-3 fatty acid intake may not reverse Alzheimer’s and may have little benefit when living with the condition. However, it means that omega-3 fatty acids would help more when their intake is increased much before the disease starts developing.

It means that low omega-3 fatty acids in the blood cells must be regarded as a modifiable risk factor for Alzheimer’s.

Are Opioids Helpful In Mental Health Improvement

There are cases of people who have a drug addiction or alcohol dependence history. In such cases, doctors might prescribe alcohol dependence treatment and addiction treatment programs while managing the symptoms of Alzheimer’s. These can also include suboxone treatment and opioid addiction treatment for mental health improvement.

Summary: A new study found that veterans are least likely to seek treatment for common health conditions such as sleep and substance use problems. The study also found that veterans were more willing to seek treatment for physical health conditions such as chronic pain and brain injuries but less willing to seek help for mental health conditions like alcohol or drug use and sleep disorders. In addition, there is a link between the willingness to seek treatment among veterans of color and incidents of discrimination. 

They have sacrificed to protect their country and experienced unique challenges due to their service. As a result, veterans are more likely to experience certain physical and mental health issues than the general population. They may also have different values and experiences that shape their perspective on life.

One of the most notable differences between veterans and the general population is the high rate of post-traumatic stress disorder (PTSD) among veterans. PTSD is a condition that can develop after someone experiences or witnesses a traumatic event. Veterans who have been in combat are at a higher risk of developing PTSD. Due to their service, they may also experience physical injuries, such as amputations or traumatic brain injuries.

Another difference between veterans and the general population is the unique stressors that veterans may face. For example, veterans may struggle with re-adjusting to civilian life after returning from deployment. They may also have difficulty finding employment or accessing healthcare. Due to these unique challenges, veterans may be more reluctant to seek help for issues such as sleep problems or substance use. They may also have different attitudes toward seeking help and may be less likely to seek help from traditional healthcare providers.

According to a recent study from the University of Missouri School of Medicine, American military veterans are the least likely to seek treatment for common health conditions such as sleep and substance use problems. The study, which included 334 veterans from 46 states, found that veterans were more willing to seek treatment for physical health conditions such as chronic pain and brain injuries but less willing to seek help for mental health conditions like alcohol or drug use and sleep disorders. The study also found a link between the willingness to seek treatment among veterans of color and incidents of discrimination.

The study involved participants from 46 states, with 66% being men and over 70% identifying as a person of color. They were asked to answer screening questions for 15 different medical conditions, such as insomnia, hazardous alcohol use, drug use, PTSD, anxiety, and depression. Additionally, they were asked to rate the importance of treatment for each health condition and their willingness to seek addiction treatment programs.

The research found that most participants were willing to seek treatment for both physical and mental health issues but were more inclined to seek treatment for physical health conditions as opposed to mental health conditions. Furthermore, the study revealed that willingness to seek treatment was highest for chronic pain, chronic medical conditions, and physical brain injuries but lowest for alcohol or drug use and sleep disorders.

The researchers suggest that this may be because sleep and alcohol problems are prevalent among veterans. Thus they may be normalized or minimized to the extent that they are not viewed as problems that need treatment such as telehealth programs. Additionally, the study looked into the impact of discrimination on seeking treatment for physical or mental health issues. The results showed that more frequent experiences of discrimination were associated with less willingness to seek treatment for physical or mental health problems.

For veterans of color, discriminatory experiences were associated with less willingness to seek treatment, but only among those who denied using other strategies for coping with stress.

The study suggests that empowering veterans to utilize healthy coping methods may mitigate the negative impact of discriminatory experiences on treatment-seeking. Additionally, doctors treating veterans must be aware of these issues, as without handling these mental health problems treating physical ailments or chronic pain may be challenging in the population group.

It is our mission to bring real hope and transformational change to patients who would otherwise be consigned to a lifetime of medications, doctor’s visits, and suffering. We expose misaligned incentives and return the power of health to the individual. We believe empowered individuals change their communities. We use a combination of lifestyle intervention, medication management, and emerging scientific research to help our patients.  When you are ready or have questions, reach out.

Medical Disclaimer: Keep in mind that the content provided is not direct medical advice for patient care, but is provided for thoughtful discussion.

Summary: Studies show that just about 40% of those who begin addiction treatment programs finish it. Moreover, treatment relapse rates are pretty high. It means that the majority of those who start substance abuse treatment fail to benefit. However, studies suggest that non-pharmacological means like regular telephonic follow-up, family support, 12 steps, and spirituality can help improve addiction recovery rates.

Many people living with addiction would like to live a healthy life. Therefore, many of them also join recovery programs. However, it is no secret that many of these de-addiction programs fail long-term. However, initial results may be pretty encouraging.

The National Substance Abuse and Mental Health Services survey shows that less than half of those who start treatment for opioid and alcohol addiction complete it. Furthermore, only about 40% of those joining treatments are estimated to finish it. Needless to say, in the long run, just a small number of them can stay clean.

All this means that only a small fraction of those joining addiction treatment programs benefit in the long run. This is a cause for worry. It means that addiction treatment is not able to help well in most cases. However, researchers think that small changes to addiction treatment can substantially increase addiction recovery rates.

Researchers have not realized the factors that influence recovery rates. Using these new techniques means that more than 70% who start substance abuse treatment can finish it, and most of them can stay clean for years. Some are able to live addiction free for the rest of their life.

The Suboxone program is another form taken up for opioid addiction treatment. 

It appears that during treatment, there is a need to resolve addictive behavior. It is about teaching those living with substance use disorder (SUD) new ways of countering their well-established habits. It is also about providing much-needed social support.

For example, a simple measure of making a phone call twice a month may help a patient stay clean. It helps them mentally and emotionally. They feel better connected with their treating doctors. Studies suggest that even such a simple measure of keeping regular contact with the patients can increase their chances of staying addiction free by almost twice. Thus, in addiction treatment, follow-up with patients is critical.

Many other factors influence long-time recoveries, like better social support, family support, and engagement with peer groups. 

Further, recovery rates can be increased significantly through a 12-steps program and spirituality. 

It is about realizing that recovery is a lifelong process. Just completing a few week-long treatments does not mean that a person will be able to stay clean for long. Thus, the two most important factors ensuring long-term recovery are social/emotional support and behavioral therapy.

A 12-step program and spirituality can also help enforce certain things. First, one needs to practice spirituality daily. It is about strengthening willpower, increasing self-confidence, and believing that one can overcome addiction. It is also about developing a moral inventory. Finally, it is about accepting shortcomings and working on them. Prayers and meditation may also help eliminate weaknesses and promote spiritual awakening.

When it comes to long-term recovery, it is not so much about drug therapy as it is about non-pharmacological means. There is increasing evidence that follow-up with patients, providing them with social support, and teaching them ways to alter their behavior can have a significant impact. 

Therefore, all those seeking treatment for their addiction must pay particular attention to the non-pharmacological treatments provided by any addiction center, like social support, 12 Steps, spirituality,  teaching social and cognitive coping, and more.

Summary: Life expectancy has increased considerably in the last few decades in the US and globally. However, this has also altered the disease pattern. A new study in the US shows that one in ten adults is now living with dementia, and another 22% are living with cognitive impairment. Since life expectancy is expected to keep rising over the next few decades, the nation and healthcare system should be better prepared to manage dementia.

In the US, average life expectancy has constantly risen since the early 20th century. Although, there has been some decline in the last few years due to Covid-19. Nonetheless, on average, people in the US can expect to live 10 years longer than in the mid-20th century.

However, the aging population also means that disease pattern is changing. Aging particularly increases the risk of brain disorders like dementia and mild cognitive impairment. The risk of dementia increases with age and due to various socio-demographic factors.

There has been no study regarding the prevalence of dementia in the US for 20 years. Thus, the new study was carried out, and its findings were published in the journal JAMA in October 2022. This new study shows that one in ten Americans live with dementia, and another 22% live with mild cognitive impairment.

This new study is important in many ways. First, it is a part of the nationally representative and long-running Health and Retirement Study. It shows the actual burden of dementia in the US. This data would help track the trends for coming years or even decades. Additionally, the study is relevant considering the impact of covid-19 on life expectancy and metabolic health in the US. 

Longevity and dementia

The study analyzed the data of 3500 adults in the Harmonized Cognitive Assessment Protocol (HCAP) Project. They were part of Michigan’s nationally representative Health and Retirement Study (HRS) done between 2016-17. All participants had to complete comprehensive neuropsychological tests that were good not only for detecting dementia but also mild cognitive impairment.

The study had many interesting findings. It found that increasing longevity has much to do with the increasing rate of dementia. Thus, the study found that the prevalence of dementia was about 3% in those 65 to 69; however, it increased to 35% in those 90 and over.

Researchers say that understanding this data is vital to prepare the healthcare system in the US better. Moreover, countering the rising rates of dementia and mild cognitive decline would require specific policy changes in the nation.

Doctors say that the number of people living with dementia and cognitive impairment is bound to increase with increasing life expectancy. This increase may be significant in the coming decades, and the nation must be prepared to meet this challenge.

Additionally, it is vital to understand the economic impact of rising dementia. It will result in added healthcare costs of about $250 billion in the US and close to a trillion US dollars worldwide.

Dementia and disparities

The study also had some other significant findings, like a higher prevalence of dementia in specific population groups. Thus, the study shows that apart from age, other factors associated with higher dementia prevalence are ethnicity, socioeconomic status, and education.

Data shows that dementia is more common among socially deprived people. Thus, the risk of dementia is relatively higher in African Americans. Mild cognitive decline is more common in Hispanics. Generally, cognitive decline is greater in people who did not obtain much education.

This data suggests the need for even more extensive population-based studies to understand how various factors increase the risk of dementia and cognitive impairment.

Finally, this study also shows an urgent need to improve diagnostic tools and prepare the healthcare system for upcoming problems.

Summary: It is no secret that socially deprived people are more likely to abuse drugs. However, the study shows a massive difference between drug overdose-related deaths among the rich and poor. Poor people are almost six times more likely to die of drug and alcohol abuse. These findings are worrisome, as drug use has risen during a pandemic. Further, researchers think reducing social inequality is vital to prevent these deaths.

Although people of different backgrounds abuse drugs, poor people are more likely to die from a drug overdose. Data analysis from England shows that this risk is almost six times higher in poor people when compared to rich people.

Their findings are relevant and worrisome. Moreover, the same data shows that the number of deaths is mounting at an incredible pace. For example, in England, deaths due to substance use disorder have risen five times in just a decade, that is, between 2010 to 2020. Of course, a similar kind of trend is seen in the US and many other nations. Thus, these findings have global relevance.

Further, it is worth noticing that these findings are from the pre-covid era. Studies in all EU nations, the UK, and the US show that drug use rose considerably during the pandemic. It means that drug addiction and drug overdose-related deaths will only climb at an even faster pace. It is a health emergency in developed nations and many parts of the world.

It is also essential to note that these findings matter due to rising social disparity. Pandemics have especially hit the poorest people in society. Thus, it means that drug use is also more likely to increase in more impoverished people compared to rich people.

Be it in the US or in the UK, opioids remain the leading cause of drug dependency-related deaths. In the UK, street drugs like heroin are more likely to cause deaths. However, in recent years, the trend is also changing in the US, where prescription drugs remain the leading cause of overdose-related deaths. In the US, street drug overdose-related deaths are rising as prescription opioids are becoming less accessible.

This UK study shows that there is a very clear and visible relationship between the economic status of people, regions, and drug overdose-related deaths. Thus, for example, people living in the most deprived areas of England are several times more likely to die of a drug overdose. It means that healthcare efforts and addiction treatment must also focus on specific geo-locations where people are more likely to abuse and overdose on drugs.

Some efforts are already being made in the US. However, many researchers have shown that in any given state, most drug overdose-related deaths occur in a few counties in the states. Hence, one of the good ideas to reduce these deaths is to create risk maps, and concentrate drug overdose-related death prevention measures in those areas, rather equally in all counties. Coming up with such risk maps is not complex, and both the financial data and data regarding drug overdose-related deaths are readily available.

There is a need to understand that, for many, drug use is just a reaction to changing the environment. They often start using drugs to overcome stress, anxiety, and other mental health issues. Many of these issues are made worse by joblessness and rising homelessness.

Additionally, it is also worth understanding that the choice of drugs by economically deprived people differs. They are more likely to use drugs that pose a greater health risk. Additionally, they are also more likely to combine multiple drugs, thus increasing the risk of a drug overdose.

Experts say that some small changes in policies are not going to help. Most of these small changes may make it harder to get drugs and reduce drug-related crime a bit. However, the impact of most such measures is small and often temporary. Addressing these economic disparities is essential to lower the risk of drug overdose-related deaths.

Therefore, if we need to overcome this issue, we need to have a broader outlook. Opioids addiction treatment will require a 360 degree approach to tackle issues at societal level. Telemedicine Addiction Treatment is one such approach that can address the issue of drug abuse economically while maintaining the comfort and privacy of a person.